AGBL2 - Agbl2 AGBL carboxypeptidase 2 Gene
Also Known as RGD1306827
Species: Rattus norvegicus
Gene Type: protein coding
Gene ID: 366124
Summary
Predicted to enable metallocarboxypeptidase activity. Predicted to be involved in protein side chain deglutamylation. Predicted to be located in centriole; ciliary basal body; and cytosol. Orthologous to human AGBL2 (AGBL Carboxypeptidase 2). [provided by Alliance of Genome Resources, Apr 2022]
AGBL2 Products (8)
| mRNA | Protein | Name |
|---|---|---|
| XM_039106794.1 | XP_038962722.1 | cytosolic carboxypeptidase 2 isoform X2 |
| XM_039106793.1 | XP_038962721.1 | cytosolic carboxypeptidase 2 isoform X2 |
| XM_039106797.1 | XP_038962725.1 | cytosolic carboxypeptidase 2 isoform X5 |
| XM_039106795.1 | XP_038962723.1 | cytosolic carboxypeptidase 2 isoform X3 |
| XM_039106792.1 | XP_038962720.1 | cytosolic carboxypeptidase 2 isoform X1 |
| XM_039106796.1 | XP_038962724.1 | cytosolic carboxypeptidase 2 isoform X4 |
| XM_039106798.1 | XP_038962726.1 | cytosolic carboxypeptidase 2 isoform X6 |
| XM_039106799.1 | XP_038962727.1 | cytosolic carboxypeptidase 2 isoform X7 |
| Protein Preferred Names | Protein Names | |
|---|---|---|
|
cytosolic carboxypeptidase 2 |
|
Related Agents
- Pre-clinical Phase
Pre-clinical Phase
Bioactive Molecules
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-RS00441 | AGBL2 Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
Compound Screening Libraries
Virtual Screening
Customize Your Library
Drug Screening Service